LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 1097 | 691 | 3846 | 0.1798 | -0.2262 |
BT-20 | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 1097 | 657 | 3673 | 0.1793 | -0.2551 |
SK-BR-3 | WZ3105 | 3.33 | uM | LJP5 | 72 | hr | 1401 | 957 | 4245 | 0.2251 | -0.2150 |
MCF7 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1316 | 4203 | 0.3136 | 0.0480 |
MCF 10A | XMD11-50 | 3.33 | uM | LJP6 | 72 | hr | 962 | 2653 | 10692 | 0.2481 | 0.3390 |
BT-20 | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 2834 | 3846 | 0.7370 | 0.6889 |
BT-20 | Radicicol | 3.33 | uM | LJP5 | 72 | hr | 1097 | 968 | 3846 | 0.2518 | -0.0669 |
BT-20 | Radicicol | 3.33 | uM | LJP6 | 72 | hr | 1097 | 1007 | 3673 | 0.2743 | -0.0480 |
SK-BR-3 | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 1401 | 3235 | 4245 | 0.7609 | 0.6836 |
MDA-MB-231 | BI-2536 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1091 | 4405 | 0.2472 | -0.0684 |
MCF 10A | R406 | 3.33 | uM | LJP6 | 72 | hr | 962 | 7814 | 10692 | 0.7310 | 0.8266 |
MCF7 | XMD11-50 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1687 | 4012 | 0.4209 | 0.2123 |
MDA-MB-231 | Withaferin A | 3.33 | uM | LJP6 | 72 | hr | 1235 | 898 | 4405 | 0.2049 | -0.1630 |
BT-20 | Withaferin A | 3.33 | uM | LJP5 | 72 | hr | 1097 | 568 | 3846 | 0.1480 | -0.3047 |
BT-20 | Withaferin A | 3.33 | uM | LJP6 | 72 | hr | 1097 | 535 | 3673 | 0.1458 | -0.3376 |